These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 735764)

  • 21. Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems.
    Brown HS; Meltzer G; Merrill RC; Fisher M; Ferré C; Place VA
    Arch Ophthalmol; 1976 Oct; 94(10):1716-9. PubMed ID: 973819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
    Jarho P; Järvinen K; Urtti A; Stella VJ; Järvinen T
    J Pharm Pharmacol; 1996 Mar; 48(3):263-9. PubMed ID: 8737051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interactions between macromolecular adjuvants and drugs. Part 19: In vitro and in vivo testing of polyvinyl alcohol and other macromolecular adjuvants as vehicles for eyedrops (author's transl)].
    Keipert S; Voigt R; Karst R; Nowak R
    Pharmazie; 1979 Dec; 34(12):818-24. PubMed ID: 545352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of different concentrations and vehicles on pilocarpine miosis. II. Different vehicles].
    Borgmann H; Wurster W
    Klin Monbl Augenheilkd; 1973 Jul; 163(1):51-6. PubMed ID: 4750513
    [No Abstract]   [Full Text] [Related]  

  • 26. Time Course of Pupil Center Location after Ocular Drug Application.
    Hoang TA; Macdonnell JE; Mangan MC; Monsour CS; Polwattage BL; Wilson SF; Suheimat M; Atchison DA
    Optom Vis Sci; 2016 Jun; 93(6):594-9. PubMed ID: 26905690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and patient acceptance of pilocarpine gel.
    Goldberg I; Ashburn FS; Kass MA; Becker B
    Am J Ophthalmol; 1979 Nov; 88(5):843-6. PubMed ID: 507163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
    Kao HJ; Lin HR; Lo YL; Yu SP
    J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Hirao K; Shimizu S; Kanetaka H; Sakurai H; Iwamoto T
    Neurosci Lett; 2007 Mar; 414(2):174-7. PubMed ID: 17197083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction Between Pilocarpine and Ripasudil on Intraocular Pressure, Pupil Diameter, and the Aqueous-Outflow Pathway.
    Yamagishi-Kimura R; Honjo M; Komizo T; Ono T; Yagi A; Lee J; Miyata K; Fujimoto T; Inoue T; Tanihara H; Nishida J; Uchida T; Araki Y; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1844-1854. PubMed ID: 29677344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.
    Järvinen T; Järvinen K; Urtti A; Thompson D; Stella VJ
    J Ocul Pharmacol Ther; 1995; 11(2):95-106. PubMed ID: 8564640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis.
    Saitoh K; Yoshida K; Hamatsu Y; Tazawa Y
    J Cataract Refract Surg; 2004 May; 30(5):1024-30. PubMed ID: 15130639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of influence of rabbit nictitating membrane of miosis effect of pilocarpine.
    DeSantis LM; Schoenwald RD
    J Pharm Sci; 1978 Aug; 67(8):1189-90. PubMed ID: 671268
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of topical administration of 2.0% pilocarpine on intraocular pressure and pupil size in cats.
    Wilkie DA; Latimer CA
    Am J Vet Res; 1991 Mar; 52(3):441-4. PubMed ID: 2035919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mydriasis from topically administered phenylephrine HCl powder.
    Thornton CN; Hanna C
    Am J Ophthalmol; 1980 Jun; 89(6):809-13. PubMed ID: 7386557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence of miosis on the central visual field].
    Fujimoto N; Adachi-Usami E; Yah LH
    Nippon Ganka Gakkai Zasshi; 1990 Dec; 94(12):1157-61. PubMed ID: 2082735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of urea on the activity of certain ophthalmic drugs in man.
    El-Nimr AE; Salama HA; Khalil RM; Kassem MA
    Pharmazie; 1983 Nov; 38(11):728-30. PubMed ID: 6689446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of drug vehicles on ocular contact time.
    Hardberger R; Hanna C; Boyd CM
    Arch Ophthalmol; 1975 Jan; 93(1):42-5. PubMed ID: 1111487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid-state ophthalmic dosage systems in effecting prolonged release of pilocarpine in the cul-de-sac.
    Loucas SP; Haddad HM
    J Pharm Sci; 1972 Jun; 61(6):985-6. PubMed ID: 5046133
    [No Abstract]   [Full Text] [Related]  

  • 40. A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy.
    Kwon HJ; Kim HY
    Korean J Ophthalmol; 2009 Dec; 23(4):291-5. PubMed ID: 20046691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.